Triple
T10292249
| Position | Surface form | Disambiguated ID | Type / Status |
|---|---|---|---|
| Subject | Genmab |
E241390
|
entity |
| Predicate | product |
P490
|
FINISHED |
| Object |
Teprotumumab
Teprotumumab is a monoclonal antibody drug used primarily to treat thyroid eye disease by targeting the insulin-like growth factor-1 receptor (IGF-1R).
|
E854987
|
NE FINISHED |
How this triple was built (4 steps)
Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.
NER
Named-entity recognition
gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: Teprotumumab | Statement: [Genmab, product, Teprotumumab]
NED1
Entity disambiguation (via context triple)
gpt-5-mini-2025-08-07
Target entity: Teprotumumab Context triple: [Genmab, product, Teprotumumab]
-
A.
Onpattro
Onpattro is an RNA interference (RNAi) therapeutic used to treat polyneuropathy in adults with hereditary transthyretin-mediated (hATTR) amyloidosis.
-
B.
Vitrakvi
Vitrakvi is a targeted cancer therapy (larotrectinib) used to treat solid tumors that have a specific NTRK gene fusion, regardless of the tumor’s location in the body.
-
C.
Zaltrap
Zaltrap is a cancer medication (brand name for aflibercept) used primarily in combination chemotherapy to treat metastatic colorectal cancer by inhibiting vascular endothelial growth factor (VEGF).
-
D.
aflibercept
Aflibercept is an anti-VEGF biologic drug used primarily to treat neovascular (wet) age-related macular degeneration and other retinal vascular diseases.
-
E.
Alimta
Alimta is a chemotherapy drug (pemetrexed) primarily used to treat malignant pleural mesothelioma and non-small cell lung cancer.
- F. None of above. chosen
- G. Unsure - the case is ambiguous/there is not enough information to decide.
NEDg
Description generation
gpt-5.1
Instruction
Generate a one-sentence description of the target entity. You are given a context triple in the form (subject, predicate, object), where the object is the target entity. # Instructions Use the triple to infer relevant information about the entity. Describe the entity based on what is most defining, well-known. Avoid repeating the information from the triple, unless really essential. # Response Format Return only the sentence: "Description: [one-sentence description of the target entity]"
Input
Entity: Teprotumumab Triple: [Genmab, product, Teprotumumab]
Generated description
Teprotumumab is a monoclonal antibody drug used primarily to treat thyroid eye disease by targeting the insulin-like growth factor-1 receptor (IGF-1R).
NED2
Entity disambiguation (via description)
gpt-5-mini-2025-08-07
Target entity: Teprotumumab Target entity description: Teprotumumab is a monoclonal antibody drug used primarily to treat thyroid eye disease by targeting the insulin-like growth factor-1 receptor (IGF-1R).
-
A.
Onpattro
Onpattro is an RNA interference (RNAi) therapeutic used to treat polyneuropathy in adults with hereditary transthyretin-mediated (hATTR) amyloidosis.
-
B.
Vitrakvi
Vitrakvi is a targeted cancer therapy (larotrectinib) used to treat solid tumors that have a specific NTRK gene fusion, regardless of the tumor’s location in the body.
-
C.
Zaltrap
Zaltrap is a cancer medication (brand name for aflibercept) used primarily in combination chemotherapy to treat metastatic colorectal cancer by inhibiting vascular endothelial growth factor (VEGF).
-
D.
aflibercept
Aflibercept is an anti-VEGF biologic drug used primarily to treat neovascular (wet) age-related macular degeneration and other retinal vascular diseases.
-
E.
Alimta
Alimta is a chemotherapy drug (pemetrexed) primarily used to treat malignant pleural mesothelioma and non-small cell lung cancer.
- F. None of above. chosen
Provenance (5 batches)
The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.
| Step | Stage | Batch ID | Status | When |
|---|---|---|---|---|
| creating | Elicitation | batch_69d381aaafc08190af475ef58dc16aba |
completed | April 6, 2026, 9:49 a.m. |
| NER | Named-entity recognition | batch_69d4d2d35f048190a215493acdf1f718 |
completed | April 7, 2026, 9:48 a.m. |
| NED1 | Entity disambiguation (via context triple) | batch_69d71d1465e88190aaa8b295df3f9c8c |
completed | April 9, 2026, 3:29 a.m. |
| NEDg | Description generation | batch_69d73180d90481908f1b4768230edd36 |
completed | April 9, 2026, 4:56 a.m. |
| NED2 | Entity disambiguation (via description) | batch_69d7326b14988190bff33dc01e690707 |
completed | April 9, 2026, 5 a.m. |
Created at: April 6, 2026, 11:42 a.m.